Latest News
Assembling a new gene therapy company to develop the next generation of pioneering medicinesJuly 25, 2021 - 11:46 am
Gene Therapy University Discounted EnrollmentJuly 22, 2021 - 8:42 am
GEN Regulatory Podcast link LIVE!July 8, 2021 - 1:57 pm
Faster, safer and affordable access to GMP grade Angiogenic Stem Cell for academic clinical trialJune 28, 2021 - 7:49 am
ImCheck: Exploring two uncharted territories in immunomodulation, butyrophilins and gamma-deltaJune 22, 2021 - 11:52 am
Making Life Science Matter and Innovation HappenJune 14, 2021 - 2:57 pm
Mind the Gaps: A Perspective from the World of Academic Spinouts
/in Uncategorized /by Michele WashkoDepending upon your perspective, “emerging” biotech could mean any number of things, ranging all the way from the recent spinout of an academic lab to a publicly held company developing a therapeutic that has not yet reached the marketplace. My company, Respana Therapeutics (a finalist in North America Advance Biotech Grant Program) sits at the […]
Investment in Internal Process Development and Manufacturing Enables Rapid Product Development
/in Bioprocessing, Frontpage Article /by Alex MeolaSpeed to the clinic and patient safety are important goals when working to bring novel genetic therapies to patients. To achieve these goals, Homology Medicines decided to invest in internal development and manufacturing operations not long after the Company’s founding, which included the construction of a 25,000 sq ft GMP manufacturing facility adjacent to its […]
CDMO: Afraid of tech transfer? There’s no need!
/in Uncategorized /by Heike MonangeTech transfer appears on the agenda of almost every biotech company. After identifying a suitable molecule, biotechs need support from external partners on the way to commercialization. However, many fear that tech transfer could slow them down or that they may be locked in with royalty fees. Working with the right partner can make all […]
Considerations for the Development of Biologics by Virtual Companies
/in News, Webinar /by Jessica HoganIf you missed the Live presentation from the Biotech Start-up Symposium you can watch it now! +2
A New Shared-risk Partnership Model for Developing and Commercializing Oncology Innovations
/in News, Webinar /by Jessica HoganIf you missed the Live presentation from the Biotech Start-up Symposium you can watch it now! +1
GEN Regulatory Podcast link LIVE!
/in News /by Jessica HoganThe success of cell and gene therapy products in recent years to treat a host of complex diseases has made production that much more critical. Many companies have begun to ramp up production timelines, so as to meet patients’ needs, while still producing efficacious and safe cell and gene therapy materials. However, many biomanufacturers have […]
Assembling a new gene therapy company to develop the next generation of pioneering medicines
/in Uncategorized /by Multiple AuthorsHaving both recently graduated from our Masters degrees, Christina in Neuroscience from ETH Zürich and Charlotte in Chemistry from The University of Edinburgh, our first days at VectorY were certainly puzzling; new faces, busy schedules, lots to learn and lots to do. Since VectorY is a start-up, founded in October 2020, we are not the […]
Gene Therapy University Discounted Enrollment
/in Uncategorized /by Jessica HoganEverything you need to know to move Gene Therapy from development to patients The field of Gene Therapy is continuing to evolve at a rapid speed and understanding the basics of viral vector manufacturing is vital to staying competitive and possibly differentiating factor in the journey commercialization. Leveraging our vast experience in viral vectors, we […]